Study of Patient Satisfaction With the Cancer Clinical Trial Experience
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Cancer
- Sponsor
- Summa Health System
- Enrollment
- 100
- Primary Endpoint
- Evaluation of surveys to determine if there are opportunities for performance and/or quality improvement projects.patient satisfaction regarding reasons for participating, facility, consent and treatment, personal issues and overall assessment.
- Status
- Completed
- Last Updated
- 13 years ago
Overview
Brief Summary
The primary objective of this study is to evaluate the quality of the clinical trial experience of cancer patients participating in cancer research studies through Summa Health System Hospitals Cancer Research Program by evaluating patient satisfaction regarding reasons for participating, facility, consent and treatment, personal issues and overall assessment.
The secondary objective of this study is to determine areas for improvement to make the patient's clinical trial experience a satisfying and positive journey.
Investigators
Joyce Neading
Program Director, Cancer Research & Cancer Registry
Summa Health System
Eligibility Criteria
Inclusion Criteria
- •Participant must have participated in a clinical trial conducted by the Summa Health System Hospitals Cancer Research Program.
- •Participant should have been registered for clinical trial participation three months prior to receiving the satisfaction survey.
Exclusion Criteria
- •Participant has withdrawn consent for clinical trial participation and/or follow up.
- •Participant has a major medical illness that would prevent completion of the survey.
Outcomes
Primary Outcomes
Evaluation of surveys to determine if there are opportunities for performance and/or quality improvement projects.patient satisfaction regarding reasons for participating, facility, consent and treatment, personal issues and overall assessment.
Time Frame: Survey will be sent to subject 3 months after study registration